Cardinal Health, Inc.
Cardinal Health, Inc.
Your view on CAH
Overview
What the company does, where it operates, and who runs it.
About Cardinal Health, Inc.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Jason M. Hollar
- Headquarters
- 7000 Cardinal Place, Dublin, OH, US
- Industry
- Medical - Distribution
- Sector
- Healthcare
- CEO
- Jason M. Hollar
- Headquarters
- 7000 Cardinal Place, Dublin, OH, US
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.
The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals.
The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.
The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits.
The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Cardinal Health, Inc. from FRC's valuation model, read against the market price. CAH last traded at $283.85, 36.6× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cardinal Health, Inc.. Starting points for Cardinal Health, Inc.: P/E 36.6, EPS $7.84, beta 0.52 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Cardinal Health, Inc.. Cardinal Health, Inc. paid $2.05 per share over the last year — a 0.7% yield at the current $283.85 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cardinal Health, Inc.. Trailing twelve-month EPS for Cardinal Health, Inc. stands at $7.84. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$288.27
average of 11 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy12
- Hold1
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | $3.13 | $3.35 | $12.90 | $14.36 |
| Low estimate | $2.91 | $2.92 | $12.51 | $13.37 |
| High estimate | $3.62 | $3.52 | $12.97 | $14.82 |
| No. of analysts | 7 | 7 | 9 | 9 |
| Year-ago EPS | $2.63 | $3.17 | $7.23 | — |
| Growth | +19.1% | +5.8% | +78.4% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | $68.30B | $63.59B | $266.15B | $281.95B |
| Low estimate | $67.83B | $62.92B | $264.39B | $275.13B |
| High estimate | $68.76B | $64.04B | $268.20B | $289.97B |
| No. of analysts | 7 | 7 | 12 | 11 |
| Year-ago revenue | $65.44B | $60.94B | $254.25B | — |
| Growth | +4.4% | +4.4% | +4.7% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cardinal Health, Inc.. Cardinal Health, Inc. has reported as a listed company since 1983. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- CORCencora, Inc.Medical - Distribution$68.1B
- HSICHenry Schein, Inc.Medical - Distribution$9.4B
- MCKMcKesson CorporationMedical - Distribution$127.6B
- SHPMYShanghai Pharmaceuticals Holding Co., LtdMedical - Distribution$5.2B
- SHTDYSinopharm Group Co. Ltd.Medical - Distribution$8.8B
- SIG.AXSigma Healthcare LimitedMedical - Distribution
More Medical - Distribution companies
- MEPDFMediPal Holdings CorporationOTC$3.9B
- NSVGFNass Valley Gateway Ltd.OTC$3M
- PDRXPD-Rx Pharmaceuticals, Inc.OTC$6M
- PGC.AXParagon Care LimitedASX
- PHRXPharmagen, Inc.OTC$5,171
- RDGTRidgetech Inc.NASDAQ$4M
- SAEYYRedcare Pharmacy N.V.OTC$1.4B
- SCRCQScripsAmerica, Inc.OTC$14,108
- SECISector 10, Inc.OTC$31
- SHPMFShanghai Pharmaceuticals Holding Co., LtdOTC$8.5B
- SHPPFRedcare Pharmacy N.V.OTC$1.5B
ETFs holding Cardinal Health, Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.09%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.08%
- VOVanguard Mid-Cap ETF$103.4B in assets0.56%
- IVViShares Core SP 500 ETF$852.9B in assets0.10%
- SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.10%
- VTVVanguard Value ETF$184.2B in assets0.21%
- SEIVSEI Enhanced U.S. Large Cap Value Factor ETF$1.6B in assets2.90%
- IYKiShares US Consumer Staples ETF$1.5B in assets2.77%
Largest holders first, then the funds most concentrated in CAH.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Cardinal Health, Inc., and how their positions are changing. At a $65.61B market value, institutional positions materially move Cardinal Health, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Cardinal Health, Inc. executives and directors. Shares of Cardinal Health, Inc. have traded between $114.60 and $208.32 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Cardinal Health, Inc.. Cardinal Health, Inc. is a $65.61B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Cardinal Health, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Cardinal Health, Inc.. Coverage tracks Cardinal Health, Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cardinal Health, Inc.